Bristol-Myers Squibb Secures EU Approval for Opdivo, Yervoy Combination in Colorectal Cancer

Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.85 USD | -0.99% |
|
-3.56% | +0.51% |
Feb. 07 | Leerink Partners Adjusts Price Target on Bristol-Myers Squibb to $68 From $73 | MT |
Feb. 07 | Wells Fargo Adjusts Price Target on Bristol-Myers Squibb to $62 From $60 | MT |